Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
71.85
+0.50 (0.70%)
Mar 9, 2026, 2:50 PM EDT - Market open
Boston Scientific Revenue
In the year 2025, Boston Scientific had annual revenue of $20.07B with 19.87% growth. Boston Scientific had revenue of $5.29B in the quarter ending December 31, 2025, with 15.90% growth.
Revenue (ttm)
$20.07B
Revenue Growth
+19.87%
P/S Ratio
5.30
Revenue / Employee
$340,237
Employees
59,000
Market Cap
106.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.07B | 3.33B | 19.87% |
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 44.33B |
| Medtronic | 35.48B |
| Stryker | 25.12B |
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Zimmer Biomet Holdings | 8.23B |
| Smith & Nephew | 6.16B |
| Edwards Lifesciences | 6.07B |
BSX News
- 18 hours ago - BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm - Business Wire
- 2 days ago - BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 3 days ago - Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology - PRNewsWire
- 5 days ago - Boston Scientific Corporation Investigated by the Portnoy Law Firm - GlobeNewsWire
- 6 days ago - Boston Scientific Corporation (BSX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 6 days ago - Baron Health Care Fund Q4 2025 Recent Activity - Seeking Alpha
- 12 days ago - Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 14 days ago - Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors - PRNewsWire